Insider · CIK 0001295829

Caldwell William S

Reports to the SEC for 1 company · WINSTON-SALEM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001295829

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-09-20	GYREGYRE THERAPEUTICS, INC.G Gift	SVP - Drug Discovery and Dev.	GGift	−500 sh	—	—	7,235
2011-09-20	GYREGYRE THERAPEUTICS, INC.G Gift	SVP - Drug Discovery and Dev.	GGift	−500 sh	—	—	6,735
2011-09-20	GYREGYRE THERAPEUTICS, INC.G Gift	SVP - Drug Discovery and Dev.	GGift	+500 sh	—	—	500
2011-03-31	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+2,655 sh	$2.93	+$7,779.15	10,390
2011-03-31	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−2,655 sh	$26.37	−$70K	7,735
2011-03-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−2,655 sh	—	—	18,595
2011-03-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	SVP - Drug Discovery and Dev.	AAward	+40K sh	—	—	40,000
2011-03-01	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+11.4K sh	$8.51	+$96.7K	19,095
2011-03-01	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−11.4K sh	$30.00	−$341K	7,735
2011-03-01	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−11.4K sh	—	—	31,472
2011-02-28	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+15.5K sh	$5.55	+$85.9K	23,216
2011-02-28	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−15.5K sh	$28.00	−$433K	7,735
2011-02-28	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−15.5K sh	—	—	0
2011-02-16	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+16.7K sh	$1.75	+$29.1K	24,390
2011-02-16	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−16.7K sh	$26.52	−$442K	7,735
2011-02-16	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−16.7K sh	—	—	21,250
2010-12-13	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+12K sh	$1.75	+$21K	19,735
2010-12-13	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−12K sh	$23.95	−$287K	7,735
2010-12-13	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−12K sh	—	—	0
2010-05-03	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+2,722 sh	$5.55	+$15.1K	10,457
2010-05-03	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+14.3K sh	$8.51	+$122K	24,735
2010-05-03	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−17K sh	$24.29	−$413K	7,735
2010-05-03	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−2,722 sh	—	—	21,547
2010-05-03	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−14.3K sh	—	—	42,832
2010-04-30	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+15.3K sh	$5.55	+$84.7K	22,998
2010-04-30	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−15.3K sh	$24.27	−$371K	7,735
2010-04-30	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−15.3K sh	—	—	24,269
2010-04-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−22K sh	—	—	33,466
2010-04-29	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+13.1K sh	$1.75	+$22.9K	20,820
2010-04-29	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+22K sh	$5.55	+$122K	42,835
2010-04-29	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−35.1K sh	$24.18	−$849K	7,735
2010-04-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−13.1K sh	—	—	12,000
2010-04-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−22K sh	—	—	39,532
2010-04-28	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+16K sh	$1.75	+$28K	23,735
2010-04-28	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−16K sh	$24.00	−$384K	7,735
2010-04-28	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−16K sh	—	—	25,085
2010-04-27	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+315 sh	$1.75	+$551.25	8,050
2010-04-27	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−315 sh	$24.00	−$7,560	7,735
2010-04-27	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−315 sh	—	—	41,085
2010-04-26	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+600 sh	$1.75	+$1,050	8,335
2010-04-26	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−600 sh	$24.00	−$14.4K	7,735
2010-04-26	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−600 sh	—	—	41,400
2010-04-20	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+7,245 sh	$5.10	+$36.9K	14,980
2010-04-20	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+8,655 sh	$5.55	+$48K	23,635
2010-04-20	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−15.9K sh	$23.00	−$366K	7,735
2010-04-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−7,245 sh	—	—	0
2010-04-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−2,589 sh	—	—	0
2010-04-20	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	−6,066 sh	—	—	55,481
2010-04-19	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	SVP - Drug Discovery and Dev.	MExercise/Conversion	+100 sh	$5.10	+$510	7,835
2010-04-19	GYREGYRE THERAPEUTICS, INC.S Sale	SVP - Drug Discovery and Dev.	SSale	−100 sh	$23.00	−$2,300	7,735

Recent filings

Accepted (ET)
Sep 294
Caldwell William S0001140361-11-047267
SEC(opens sec.gov)
Apr 44
Caldwell William S0001140361-11-020669
SEC(opens sec.gov)
Mar 314
Caldwell William S0001140361-11-019843
SEC(opens sec.gov)
Mar 24/A
Caldwell William S0001140361-11-013589
SEC(opens sec.gov)
Mar 24
Caldwell William S0001140361-11-013592
SEC(opens sec.gov)
Feb 184
Caldwell William S0001140361-11-010810
SEC(opens sec.gov)
Dec 144
Caldwell William S0001140361-10-049584
SEC(opens sec.gov)

Companies

GYRE THERAPEUTICS, INC.SVP - Drug Discovery and Dev.GYRE

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101